One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
Saved in:
| Title: | One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. |
|---|---|
| Authors: | Henry O; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com., Brzostek J; Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy_br@poczta.onet.pl., Czajka H; Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl., Leviniene G; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com., Reshetko O; Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru., Gasparini R; Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it., Pazdiora P; Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz., Plesca D; Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com., Desole MG; Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it., Kevalas R; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt., Gabutti G; Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it., Povey M; Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com., Innis B; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com. |
| Source: | Vaccine [Vaccine] 2018 Jan 08; Vol. 36 (3), pp. 381-387. Date of Electronic Publication: 2017 Dec 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29224964 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Henry+O%22">Henry O</searchLink>; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com.<br /><searchLink fieldCode="AU" term="%22Brzostek+J%22">Brzostek J</searchLink>; Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy&#95;br@poczta.onet.pl.<br /><searchLink fieldCode="AU" term="%22Czajka+H%22">Czajka H</searchLink>; Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl.<br /><searchLink fieldCode="AU" term="%22Leviniene+G%22">Leviniene G</searchLink>; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com.<br /><searchLink fieldCode="AU" term="%22Reshetko+O%22">Reshetko O</searchLink>; Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru.<br /><searchLink fieldCode="AU" term="%22Gasparini+R%22">Gasparini R</searchLink>; Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it.<br /><searchLink fieldCode="AU" term="%22Pazdiora+P%22">Pazdiora P</searchLink>; Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz.<br /><searchLink fieldCode="AU" term="%22Plesca+D%22">Plesca D</searchLink>; Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com.<br /><searchLink fieldCode="AU" term="%22Desole+MG%22">Desole MG</searchLink>; Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it.<br /><searchLink fieldCode="AU" term="%22Kevalas+R%22">Kevalas R</searchLink>; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt.<br /><searchLink fieldCode="AU" term="%22Gabutti+G%22">Gabutti G</searchLink>; Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it.<br /><searchLink fieldCode="AU" term="%22Povey+M%22">Povey M</searchLink>; Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com.<br /><searchLink fieldCode="AU" term="%22Innis+B%22">Innis B</searchLink>; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2018 Jan 08; Vol. 36 (3), pp. 381-387. <i>Date of Electronic Publication: </i>2017 Dec 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29224964 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2017.11.081 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 381 Titles: – TitleFull: One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Henry O – PersonEntity: Name: NameFull: Brzostek J – PersonEntity: Name: NameFull: Czajka H – PersonEntity: Name: NameFull: Leviniene G – PersonEntity: Name: NameFull: Reshetko O – PersonEntity: Name: NameFull: Gasparini R – PersonEntity: Name: NameFull: Pazdiora P – PersonEntity: Name: NameFull: Plesca D – PersonEntity: Name: NameFull: Desole MG – PersonEntity: Name: NameFull: Kevalas R – PersonEntity: Name: NameFull: Gabutti G – PersonEntity: Name: NameFull: Povey M – PersonEntity: Name: NameFull: Innis B IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 01 Text: 2018 Jan 08 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 36 – Type: issue Value: 3 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
